Detalhe da pesquisa
1.
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries.
Ann Rheum Dis
; 82(5): 698-709, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36787993
2.
Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry).
J Clin Rheumatol
; 29(2): 68-77, 2023 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454054
3.
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
Clin Rheumatol
; 42(2): 563-578, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201124
4.
An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
Clin Rheumatol
; 41(10): 3199-3209, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35760939
5.
Lupus en Argentina. Pacientes no respondedores al tratamiento estándar y belimumab como posible opción. Datos del registro RELESSAR / Lupus in Argentina. Non-responders to standard treatment and belimumab as a possible option. RELESSAR record data
Rev. argent. reumatolg. (En línea)
; 33(1): 14-25, ene. - mar. 2022. tab
Artigo
em Espanhol
| LILACS, BINACIS | ID: biblio-1394706
6.
Lupus en Argentina. Pacientes no respondedores al tratamiento estándar y belimumab como posible opción. Datos del registro RELESSAR / Lupus in Argentina. Non-responders to standard treatment and belimumab as a possible option. RELESSAR record data
Rev. argent. reumatolg. (En línea)
; 33(1): 14-25, ene. - mar. 2022. tab
Artigo
em Espanhol
| LILACS, BINACIS | ID: biblio-1392898